This impurity is related to Lanreotide Anti-parallel Dimer is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Lanreotide Anti-parallel Dimer is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(4R,7S,10S,13R,16S,19R,24R,27S,30S,33R,36S,39R)-13,33-bis((1H-indol-3-yl)methyl)-19,39-bis((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N4,N24-bis((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10,30-bis(4-aminobutyl)-16,36-bis(4-hydroxybenzyl)-7,27-diisopropyl-6,9,12,15,18,26,29,32,35,38-decaoxo-1,2,21,22-tetrathia-5,8,11,14,17,25,28,31,34,37-decaazacyclotetracontane-4,24-dicarboxamideCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Lanreotide Molecular Formula: C108H138N22O20S4
Molecular Weight: 2192.7
Storage: Store in a cool, dry place.